Post Type Archives: News

Highly potent drugs now account for over 30% of the global pipeline, with more than 1,000 molecules in development, Axplora’s investments in HPAPI capacity help customers bring these complex therapies to market faster $60 million investment to expand highly potent API (HPAPI) development and manufacturing at Axplora’s Farmabios site in Gropello Cairoli, Italy New 4,500 […]

This significant milestone demonstrates the facility’s advanced capabilities, operational efficiency, and technical expertise. With this achievement, Piramal strengthens its leadership position in delivering critical bioconjugate therapies to patients in need. Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA | BSE: 543635), is proud […]

Lab Thread Ltd, a UK-based life science software company, today announced the release of a free of charge version of the Company’s Unified Lab Software Platform, available to academic and non-profit researchers worldwide. The software provides a range of core modules tailored to support early-stage research – offering an intuitive and collaborative system that enables […]

Kindeva, a global drug delivery contract development and manufacturing organization (CDMO), has today announced the appointment of Mike Cowhig to the role of Chief Legal Officer, to drive legal strategy, enterprise risk management and corporate governance across the organization. Bringing over 25 years of experience in the life sciences industry, Mike has previously held several […]

Mabion has secured up to EUR 3.1 million in loan financing from the Japanese company CBC Co., Ltd. to support short-term liquidity and ensure operational continuity in the period preceding a planned capital increase This transaction represents the third external debt financing secured by the Company in recent months, following previous bridge loans from Twiti […]

The company’s latest flow chemistry investment strengthens continuous processing offering for clinical and commercial manufacturing programs Almac Sciences, a member of the Almac Group, is pleased to announce a significant expansion of its API and flow chemistry services with the launch of cGMP compliant flow high pressure hydrogenation. This new capability brings enhanced precision, safety, and scalability to one of the most critical transformations in modern synthetic chemistry […]

SK pharmteco announced the successful CGMP qualification of its manufacturing facility in Corbeil-Essonnes, France. This state-of-the-art plant is now fully operational and prepared to support late-stage and commercial viral vector programs at scale. Recently, the facility was inspected by the ANSM (French Health Authority) and was successfully approved for operations. It has since produced its first batch using the company’s proprietary AAVelocity™ platform, […]

FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced the appointment of Christiane Bardroff as Chief Business Officer (CBO), effective June 1, 2026. Bardroff will lead commercial and sales, business insights and intelligence, strategic partnerships and global marketing, reporting directly to President and CEO Lars Petersen. Bardroff brings […]

Chiesi Group, the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long–standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon […]